ON101 (FESPIXON®)
Diabetic Foot Ulcer
Phase 3Active
Key Facts
About Oneness Biotech
Taiwanese biotech delivering Phase 3 wound‑care therapy and a diversified pipeline across dermatology, immunology and metabolism.
View full company profileTherapeutic Areas
Other Diabetic Foot Ulcer Drugs
| Drug | Company | Phase |
|---|---|---|
| Woxheal | Centaur Pharmaceuticals | Phase 3 |
| Stempeucel® | Stempeutics Research | Phase 3 |
| C2C_ASC | Cell2Cure | Phase 1/2 |
| ENERGI‑F703EB Cream | Energenesis Biomedical | Phase 2 |